Trauma: Bleeding, coagulopathy, and blood component transfusion

Intensive Care Medicine: Annual Update 2006

Volumn , Issue , 2007, Pages 255-264

  Rossaint, R ^a   Spahn, D R ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892247217     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-35096-9_24     Document Type: Chapter

References (50)

1. World Health Organization (2003) World Health Report 2003: Shaping the Future. World Health Organization, Geneva
2. Holcomb JB (2004) Methods for improved hemorrhage control. Crit Care 8 (suppl 2):S57-S60
3. Hoyt DB (2004) A clinical review of bleeding dilemmas in trauma. Semin Hematol 41 (suppl 0:40-43
4. Sauaia A, Moore FA, Moore EE, et al (1995) Epidemiology of trauma deaths: a reassessment. J Trauma 38:185-193
5. Carrico CJ, Holcomb JB, Chaudry IH; PULSE Trauma Work Group (2002) Post resuscitative and initial utility of life saving efforts. Scientific priorities and strategic planning for resuscitation research and life saving therapy following traumatic injury: report of the PULSE Trauma Work Group. Acad Emerg Med 9:621-626
6. Lynn M, Jeroukhimov I, Klein Y, Martinowitz U (2002) Updates in the management of severe coagulopathy in trauma patients. Intensive Care Med 28 (suppl 2):S241-S247
7. MacLeod JBA, Lynn M, McKenney MG, Cohn SM, Murtha M (2003) Early coagulopathy predicts mortality in trauma. J Trauma 55:39-44
8. Spahn DR, Rossaint R (2005) Coagulopathy and blood component transfusion in trauma. Br J Anaesth 95:130-139
9. Bombeli T, Spahn DR (2004) Updates on perioperative coagulation: physiology and management of thromboembolism and haemorrhage. Br J Anaesth 93:275-287
10. Hoffman M (2003) A cell-based model of coagulation and the role of factor Vila. Blood Rev 17 (suppl 1):S1-S5
11. Moore EE (1996) Thomas G. Orr Memorial Lecture. Staged laparotomy for the hypothermia, acidosis, and coagulopathy syndrome. Am J Surg 172:405-410
12. Cosgriff N, Moore EE, Sauia A, Kenny-Moynihan M, Burch JM, Galloway B (1997) Predicting life-threatening coagulopathy in the massively transfused trauma patient. Hypothermia and acidosis revisited. J Trauma 42:857-861
13. Reiss RF (2000) Hemostatic defects in massive transfusion: rapid diagnosis and management. Am J Crit Care 9:158-165
14. Hardaway RM (1995) Trauma, sepsis, and disseminated intravascular coagulation. J Intensive Care Med 10:145-152
15. Ferrara A, MacArthur JD, Wright HK, Modlin IM, McMillen MA (1990) Hypothermia and acidosis worsen coagulopathy in the patient requiring massive transfusion. Am J Surg 160:515-518
16. MacLeod J, Lynn M, McKenney MG, Jeroukhimov I, Cohn SM (2004) Predictors of mortality in trauma patients. Am Surg 70:805-810
17. Faringer PD, Mullins RJ, Johnson RL, Trunkey DD (1993) Blood component supplementation during massive transfusion of AS-1 red cells in trauma patients. J Trauma 34:481-485
18. Wolberg AS, Meng ZG, Monroe DM III, Hoffman M (2004) A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. J Trauma 56:1221-1228
19. Meng ZH, Wolberg AS, Monroe DM III, Hoffmann M (2003) The effects of temperature and pH on the activity of factor Vila in hypothermic and acidotic patients. J Trauma 55:886-891
20. Council of Europe Publishing. 2004. Guide to the Preparation, Use and Quality Assurance of Blood Components. Council of Europe Publishing, Strasburg
21. Stehling LC, Doherty DC, Faust RJ, et al (1996) Practice guidelines for blood component therapy: a report by the American Society of Anesthesiologists Task Force on Blood Component therapy. Anesthesiology 84:732-747
22. Martinowitz U, Michaelson M; The Israeli Multidisciplinary rFVIIa Task Force (2005) Guidelines for the use of recombinant activated factor Vila in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force. J Thromb Haemost 3:640-648
23. Dzik WH (2004) Predicting hemorrhage using preoperative coagulation screening assays. Curr Hematol Rep 3:324-330
24. Armand R, Hess JR (2003) Treating coagulopathy in trauma patients. Transfus Med Rev 17:223-231
25. Hardy JF, Samama M (2003) Massive transfusion and coagulopathy. TATM 4:199-210
26. Shafi S, Kauder DR (2004) Fluid resuscitation and blood replacement in patients with polytrauma. Clin Orthop Relat Res 422:37-42
27. Claridge JA, Sawyer RG, Schulman AM, McLemore EC, Young JS (2002) Blood transfusions correlate with infections in trauma patients in a dose-dependent manner. Am Surg 68:566-572
28. Edna TH, Bierkeset T (1992) Association between blood transfusion and infection in injured patients. J Trauma 33:659-661
29. Moore FA, Moore EE, Sauaia A (1997) Blood transfusion. An independent risk factor for postiniury multiple organ failure. Arch Surg 132:620-624
30. Como JJ, Dutton RP, Scalea TM, Edelman BB, Hess JR (2004) Blood transfusion rates in the care of acute trauma. Transfusion 44:809-813
31. Malone DL, Dunne J, Tracy JK, Putnam AT, Scalea TM, Napolitano LM (2003) Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 54:898-905
32. Zallen G, Offner PJ, Moore EE, et al (1999) Age of transfused blood is an independent risk factor for postiniury multiple organ failure. Am J Surg 178:570-572
33. Vaslef SN, Knudsen NW, Neligan PJ, Sebastian MW (2002) Massive transfusion exceeding 50 units of blood products in trauma patients. J Trauma 53:291-295
34. Blaichman MA (2002) Immunomodulation and blood transfusion. Am J Ther 9:389-395
35. Schulman CI, Cohn SM (2004) Transfusion in surgery and trauma. Crit Care Clin 20:281-297
36. Leal-Noval SR, Jara-Lopez I, Garcia-Garmendia JL, et al (2003) Influence of erythrocyte concentration storage time on postsurgical morbidity in cardiac patients. Anesthesiology 98:815-822
37. Herbert PC, Wells G, Blaichman MA, et al (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 340:409-417
38. Mclntyre L, Hebert PC, Wells G, et al (2004) Is a restrictive transfusion strategy safe for resuscitated and critically ill trauma patients? J Trauma 57:563-568
39. Hiippala S (1998) Replacement of massive blood loss. Vox Sang 74 (suppl 2):399-407
40. Stainsby D, MacLennan S, Hamilton PJ (2000) Management of massive blood loss: a template guideline. Br J Anaesth 85:487-491
41. Chowdhury P, Saaman AG, Paulus U, Findlay GP, Collins PW (2004) Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 125:69-73
42. Grosso SM, Keenan JO (2000) Whole blood transfusion for exsanguinating coagulopathy in a US filed surgical hospital in postwar Kosovo. J Trauma 49:145-148
43. Moore FA, McKinley BA, Moore EE (2004) The next generation in shock resuscitation. Lancet 363:1988-1996
44. Jurlander B, Thim L, Klausen NK, et al (2001) Recombinant activated factor VII (rFVIIa): characterization, manufacturing, and clinical development. Semin Thromb Hemost 27:373-383
45. Hoffman M, Monroe DM, Roberts HR (1998) Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII. Blood Coagul Fibrinolysis 9:S61-S65
46. Monroe DM, Hoffman M, Oliver JA, Roberts HR (1998) A possible mechanism of action of activated factor VII independent of tissue factor. Blood Coagul Fibrinolysis 9:S15-S20
47. Dutton RP, McCunn M, Hyder M, et al (2004) Factor Vila for correction of traumatic coagulopathy. J Trauma 57:709-719
48. Grounds M (2003) Recombinant factor Vila (rFVIIa) and its use in severe bleeding in surgery and trauma: a review. Blood Rev 17:S11-S21
49. Levi M, Peters M, Buller HR (2005) Efficacy and safety of recombinant factor Vila for treatment of severe bleeding: a systematic review. Crit Care Med 33:883-890
50. Boffard KD, Riou B, Warren B, et al (2005) Recombinant factor Vila as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 59:8-18